These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28853229)

  • 1. Average spectral power changes at the hippocampal electroencephalogram in schizophrenia model induced by ketamine.
    Sampaio LRL; Borges LTN; Silva JMF; de Andrade FRO; Barbosa TM; Oliveira TQ; Macedo D; Lima RF; Dantas LP; Patrocinio MCA; do Vale OC; Vasconcelos SMM
    Fundam Clin Pharmacol; 2018 Feb; 32(1):60-68. PubMed ID: 28853229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electroencephalographic study of chlorpromazine alone or combined with alpha-lipoic acid in a model of schizophrenia induced by ketamine in rats.
    Sampaio LRL; Borges LTN; Barbosa TM; Matos NCB; Lima RF; Oliveira MN; Gularte VN; Patrocínio MCA; Macêdo D; Vale OCD; Vasconcelos SMM
    J Psychiatr Res; 2017 Mar; 86():73-82. PubMed ID: 27951451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia.
    Becker A; Peters B; Schroeder H; Mann T; Huether G; Grecksch G
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):687-700. PubMed ID: 12787858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advantages of the Alpha-lipoic Acid Association with Chlorpromazine in a Model of Schizophrenia Induced by Ketamine in Rats: Behavioral and Oxidative Stress evidences.
    Sampaio LRL; Cysne Filho FMS; de Almeida JC; Diniz DDS; Patrocínio CFV; de Sousa CNS; Patrocínio MCA; Macêdo D; Vasconcelos SMM
    Neuroscience; 2018 Mar; 373():72-81. PubMed ID: 29337238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictive validity.
    Becker A; Grecksch G
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1267-77. PubMed ID: 15588753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preventive effects of ascorbic acid supplementation on locomotor and acetylcholinesterase activity in an animal model of schizophrenia induced by ketamine.
    Damazio LS; Silveira FR; Canever L; Castro AA; Estrela JM; Budni J; Zugno AI
    An Acad Bras Cienc; 2017; 89(2):1133-1141. PubMed ID: 28513779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sepsis on behavioral changes on the ketamine-induced animal model of schizophrenia.
    Comim CM; Silva NC; Patrício JJ; Palmas D; Mendonça BP; Bittencourt MO; Cassol OJ; Barichello T; Zugno AI; Quevedo J; Dal-Pizzol F
    J Neuroimmunol; 2015 Apr; 281():78-82. PubMed ID: 25867472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia.
    Kandratavicius L; Balista PA; Wolf DC; Abrao J; Evora PR; Rodrigues AJ; Chaves C; Maia-de-Oliveira JP; Leite JP; Dursun SM; Baker GB; Guimaraes FS; Hallak JE
    BMC Neurosci; 2015 Mar; 16():9. PubMed ID: 25887360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coupling in the cortico-basal ganglia circuit is aberrant in the ketamine model of schizophrenia.
    Cordon I; Nicolás MJ; Arrieta S; Lopetegui E; López-Azcárate J; Alegre M; Artieda J; Valencia M
    Eur Neuropsychopharmacol; 2015 Aug; 25(8):1375-87. PubMed ID: 25910422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morin Attenuates Neurochemical Changes and Increased Oxidative/Nitrergic Stress in Brains of Mice Exposed to Ketamine: Prevention and Reversal of Schizophrenia-Like Symptoms.
    Ben-Azu B; Aderibigbe AO; Eneni AO; Ajayi AM; Umukoro S; Iwalewa EO
    Neurochem Res; 2018 Sep; 43(9):1745-1755. PubMed ID: 29956036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hippocampal complexin proteins and cognitive dysfunction in schizophrenia.
    Sawada K; Barr AM; Nakamura M; Arima K; Young CE; Dwork AJ; Falkai P; Phillips AG; Honer WG
    Arch Gen Psychiatry; 2005 Mar; 62(3):263-72. PubMed ID: 15753239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prepubertal chronic stress and ketamine administration to rats as a neurodevelopmental model of schizophrenia symptomatology.
    Ram E; Raphaeli S; Avital A
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2307-14. PubMed ID: 23915719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms.
    Vasconcelos GS; Ximenes NC; de Sousa CN; Oliveira Tde Q; Lima LL; de Lucena DF; Gama CS; Macêdo D; Vasconcelos SM
    Schizophr Res; 2015 Jul; 165(2-3):163-70. PubMed ID: 25937462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in mice.
    Hou Y; Zhang H; Xie G; Cao X; Zhao Y; Liu Y; Mao Z; Yang J; Wu C
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():107-16. PubMed ID: 23603358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardized extract of Erythrina velutina Willd. attenuates schizophrenia-Like behaviours and oxidative parameters in experimental animal models.
    Dias KCF; de Almeida JC; Vasconcelos LC; Patrocínio MLV; Barbosa TM; Ximenes NC; Leitão APA; Louchard BO; Pimenta ATÁ; Pinto FDCL; Leal LKAM; Honório Junior JER; Vasconcelos SMM
    J Pharm Pharmacol; 2019 Mar; 71(3):379-389. PubMed ID: 30456833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia.
    Becker A; Grecksch G; Zernig G; Ladstaetter E; Hiemke C; Schmitt U
    Psychopharmacology (Berl); 2009 Mar; 202(4):579-87. PubMed ID: 18810393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain sensitivity is altered in animals after subchronic ketamine treatment.
    Becker A; Grecksch G; Schröder H
    Psychopharmacology (Berl); 2006 Dec; 189(2):237-47. PubMed ID: 17016710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanolic extract of Erythrina velutina Willd ameliorate schizophrenia-like behavior induced by ketamine in mice.
    Ximenes NC; Dos Santos Júnior MA; Vasconcelos GS; Dias KCF; Jucá MM; Silva AH; Leal LKAM; Viana GSB; de Sousa FCF; Vasconcelos SMM
    J Complement Integr Med; 2018 Oct; 16(2):. PubMed ID: 30315736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of omega-3 dietary supplement in prevention of positive, negative and cognitive symptoms: a study in adolescent rats with ketamine-induced model of schizophrenia.
    Gama CS; Canever L; Panizzutti B; Gubert C; Stertz L; Massuda R; Pedrini M; de Lucena DF; Luca RD; Fraga DB; Heylmann AS; Deroza PF; Zugno AI
    Schizophr Res; 2012 Nov; 141(2-3):162-7. PubMed ID: 22954755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitroprusside single-dose prevents the psychosis-like behavior induced by ketamine in rats for up to one week.
    Maia-de-Oliveira JP; Lobão-Soares B; Ramalho T; Gavioli EC; Soares VP; Teixeira L; Baker GB; Dursun SM; Hallak JE
    Schizophr Res; 2015 Mar; 162(1-3):211-5. PubMed ID: 25586741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.